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Renal blood oxygen level–dependent magnetic resonance
imaging (BOLD-MRI) is a noninvasive fast technique to
characterize renal function. Here we evaluated the impact
of renal function on the relaxation rate (R2*) in the cortex
and medulla to provide baseline data for further use of
renal BOLD-MRI. This parameter was evaluated in 400
patients scheduled for abdominal imaging who underwent
transversal blood oxygen level–dependent measurements
with a multi-echo gradient-echo sequence with 12 echo
times. The loss of phase coherence (T2*) maps were
generated in which kidney regions of interest were
selected to differentiate the medulla and cortex, and R2*
was equated to 1/T2*. Individual R2* values were, in turn,
correlated to the eGFR (MDRD formula of 280 patients with
available serum creatinine measurements), age, and gender
each for 1.5 and 3.0 T field-strength scans of 342 patients.
At both the field strengths, no significant differences in R2*
of the cortex and medulla were found between patient
gender, age, eGFR, or between different stages of chronic
kidney disease determined using the KDOQI system. Thus,
BOLD-MRI of a non-specific patient population failed to
discriminate between the patients with various stages of
chronic kidney disease.
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Functional magnetic resonance (MR) imaging of the kidneys
has evolved into a clinically broadly applied tool. Clinically
applied methods of functional imaging comprise contrast-
enhanced MR perfusion and filtration measurements,1,2 the
assessment of split renal function3 and diffusion-weighted
imaging, which is particularly used for characterization of
renal masses and inflammatory changes of the kidneys.4–6 A
recent study could even demonstrates that the diffusion-
weighted imaging–derived apparent diffusion coefficient
correlates with the overall renal function and demonstrates
a continuous decrease with decreasing renal function.7 Blood
oxygen level–dependent MR imaging (BOLD-MRI) has so far
primarily been used for functional imaging of the brain.
In abdominal imaging, BOLD has been embraced as a non-
invasive fast technique that allows to indirectly monitor the
degree of renal oxygenation. The R2* value, which can be
derived from renal BOLD measurements, correlates inversely
with the oxygenation level but does not allow to absolutely
quantify the oxygen content. As the renal medulla even under
physiological conditions works at the brink of hypoxia,8
alterations of the medullary oxygen content are supposed to
be a direct consequence of altered medullary perfusion.9
Published studies on the renal BOLD imaging mainly focused
on intraindividual changes of the medullary and cortical R2*
in patients and volunteers after waterload or pharmacological
stimulation.10–13 A few studies also investigated the potential
of renal BOLD-MRI to detect renal disease, particularly in
renal transplants.14–16 In a study by Djamali et al.16 reduced
medullary and cortical R2* values were found in patients
with chronic allograft nephropathy when compared to a
group of healthy volunteers, indicating an increased local
oxygen content in the chronic allograft nephropathy kidneys.
In contrast, Thoeny et al.17 found a slightly increased R2* in
patients with clinically stable renal allografts when compared
to age- and sex-matched healthy volunteers indicating
hypoxic changes in renal allografts. In a further study on
renal allograft BOLD-MRI by Djamali et al.,15 higher R2*
values were found in functioning allografts than in those with
acute rejection or acute tubular necrosis. Overall, these
studies investigated only a few aspects of renal BOLD-MRI in
a limited selected patient group. The differences between the
measured R2* values in the diseased group of these studies
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and the control groups were often rather small and only
detectable when the mean values of the various groups were
compared. Little is so far known about the natural
distribution of R2* with regard to patient’s age, gender, and
particularly renal function. Therefore, the aim of this study
was to evaluate the impact of renal function on cortical and
medullary R2* to provide robust baseline data for further
scientific use of renal BOLD-MRI.
RESULTS
Assessable patients and general consideration
Of the 400 patients included in this study, 342 could be
successfully analyzed (Figure 1). The main reasons for the
dropout of 58 patients were: severe motion/respiratory
artifacts in 43 patients, erroneous acquisition of the BOLD
images after MR-contrast application in 5 patients, poor
image quality making an analysis impossible in 5 patients,
atrophy of two kidneys, and increased susceptibility due to
air-filled colon loops or spinal orthopedic instrumentation
leading to non-diagnostic BOLD images. Hence, the overall
success rate of the BOLD measurements was 85.5%.
The mean cortical R2* and medullary R2* at 1.5 T were
12.4±2.3Hz and 21.2±4.9Hz, respectively. At 3.0 T, the
respective results of cortical R2* and medullary R2* were
18.7±5.4Hz and 32.0±7.7Hz, respectively. These values are
located within the range of reported renal R2* values in the
literature, and the 50% increase in R2* seen with the
transition to 3.0 T was also predicted.
Impact of renal function on R2*
Of the 343 patients in whom cortical R2* and medullary R2*
could be measured, estimated glomerular filtration rate
(eGFR) was available for 280 patients (Figure 1): 172 (107
male, 65 female) at 1.5 T and 108 (68 male, 40 female) at
3.0 T. There was no correlation between the eGFR, and the
medullary and cortical R2* (Figure 2). Correlation coeffi-
cients were 0.02 (medullary R2*) and 0.24 (cortical R2*)
at 1.5 T, and 0.01 (medullary R2*) and 0.04 (cortical R2*)
at 3.0 T. As the Modification of Diet in Renal Disease
(MDRD) formula may yield invalid results for patients with a
GFR460ml/min, the correlation analysis was also separately
performed for the patients with Kidney Disease Outcomes
Quality Initiative (KDOQI) stage 3–5 disease. For these, the
corresponding correlation coefficients were 0.05 (medullary
R2*) and 0.02 (cortical R2*) at 1.5 T, and 0.01 (medullary
R2*) and 0.13 (cortical R2*) at 3.0 T. The subgroup-wise
analysis of medullary R2*and cortical R2* with regard to the
KDOQI subgroups revealed no significant differences bet-
ween any of the subgroups (Figure 3). The mean cortical
R2*/medullary R2* of the KDQOI stage 1–2 subgroup was
17.7Hz/30.9Hz at 3.0 T and 12.4Hz/21.4Hz at 1.5 T. The
corresponding values of the KDQOI stage 3–5 subgroup
was 21.1Hz/33.1Hz at 3.0 T and 13.0Hz/22.3 Hz at 1.5 T.
Between both the groups no significant differences were
found despite the slight tendency towards higher R2* values
in the KDQOI stage 3–5 subgroups.
Impact of age, gender, and renal artery stenosis on R2*
For this analysis, all 343 patients with analyzable kidneys
were included. There was no statistically significant difference
between the cortical and medullary R2* values found in
males and females, neither at 1.5 T nor at 3.0 T, even though
the cortical R2*and medullary R2* values in female patients
were slightly lower than in male patients (Table 1). Equally,
no correlation between age and medullary R2* or cortical R2*
was observed (Figure 4). The correlation coefficients were
0.17 (medullary R2* at 1.5 T), 0.04 (cortical R2* at 1.5 T),
400 Patients
62 Patients w/o
creatinine
58 Patients not
analyzable
280 Patients with R2*
and eGFR
342 Patients with measureable
 R2* values
172 at 1.5 T — 107 M, 65 F
108 at 3.0 T — 68 M, 40 F
211 at 1.5 T — 129 M, 82 F
131 at 3.0 T — 82 M, 49 F
Figure 1 | Flowchart of the included patients.
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Figure 2 |Graphic depiction of MR2* and CR2* distribution as
a function of several parameters. Dot plots that demonstrate
no correlation between the estimated glomerular filtration rate
(eGFR) and medullary relaxation rate (MR2*) or cortical relaxation
rate (CR2*) at (a) 1.5 T or (b) 3.0 T.
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0.03 (medullary R2* at 3.0 T), and 0.04 (cortical R2* at
3.0 T). Among the 81 patients who underwent contrast-
enhanced MR angiography of the abdomen, 31 patients with
a renal artery stenosis X50% were identified (5 at 1.5 T and
26 at 3.0 T). The medullary and cortical R2* values were not
statistically significant between patients with renal artery
stenosis and those with contrast-enhanced MR angiography,
but without renal artery stenosis.
DISCUSSION
This study is the largest study reporting on BOLD imaging
outside of the brain and in which the BOLD measurement
has been incorporated into the clinical examination protocols
in routine patients. R2* is a quantitative parameter calculated
from multi-echo T2*-weighted images and represents the
tissue-specific relaxation rate. R2* was found to correlate
inversely with the local oxygen concentration,9 yet it does not
allow to absolutely quantify the tissue oxygen concentration.
In rat studies, renal BOLD MR imaging showed a good
correlation to fiber-optic measurements of renal oxygena-
tion.13 The findings that can be derived from this study are
multiple. First, even though the acquisition of the sequence is
technically not demanding, the overall success rate was only
85.5%. Most of the patients that were non-assessable simply
did not hold their breath as expected. In previous studies
focusing only on R2* measurements, this problem was not
reported.14–16,18–20 This problem could be overcome by
adjusting the sequence and either acquiring less slices—at
the danger of having no artifact-free images or by reducing
the number of echoes that would deteriorate the quality of
the T2* fitting. Second, the present data also correspond to
the published literature with regard to the absolute value of
medullary and cortical R2*.16,18 Of interest is the transition
to 3.0 T where the inherently fourfold higher susceptibility of
3.0 T leads to an increased R2* both in the medulla and in the
kidney, and facilitated the differentiation of both during the
image analysis. However, at 3.0 T the number of artifacts that
occurred owing to susceptibility was higher and affected
more often the kidneys (particularly, susceptibility artifacts
caused by air-filled large bowel loops in the right upper
quadrant). The precision of the measurements at 3.0 T also
seems to be inferior to the 1.5 T data, which can be deducted
from the higher standard deviations throughout all measure-
ments at 3.0 T. Therefore, the answer to the question which
field strength seems to be most favorable for BOLD imaging
cannot be inferred from this study.
The primary aim of this study was to assess whether
different stages of renal function—estimated by the eGFR—
Table 1 | Overview of results for cortical R2* (1/s) and
medullary R2* (1/s) by gender
Female Male P-value
1.5 T
Cortical R2* 12.0±1.5 12.6±2.6 NS
Medullary R2* 20.9±2.9 21.4±5.4 NS
3.0 T
Cortical R2* 17.8±4.3 19.3±6.0 NS
Medullary R2* 31.1±8.1 32.5±7.5 NS
Abbreviations: NS, nonsignificant; R2*, relaxation rate.
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Figure 3 |Graphic depiction of MR2* and CR2* distribution as a function of several parameters. In the subgroup analysis with patients
stratified by renal function based on the Kidney Disease Outcomes Quality Initiative (KDOQI) groups, no significant differences between
any of the groups can be appreciated at (a, c) 1.5 T or (b, d) 3.0 T. The symbols (x and +) represent outliers beyond the 75% confidence
interval and were introduced by the statistical software. CR2*, cortical relaxation rate; MR2*, medullary relaxation rate.
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lead to a decrease in intrarenal oxygenation and hence an
increase in medullary R2* or cortical R2*. Particularly for the
oxygen-deprived medulla this could have been expected. In a
recent study by Xu et al.,7 a decrease in renal apparent
diffusion coefficient was seen with decreasing renal function.
This could be explained by an increasing fibrosis of the renal
interstitium as suggested by a recent animal study.21 This
study proves that the notion, that the loss of renal function
with concordant loss of glomeruli and renal fibrosis is also
associated with a decreased intrarenal oxygenation, is wrong.
In another recent study, R2* was measured in the kidneys
downstream a unilateral renal artery stenosis in a rat model.22
In this study no difference in medullary R2* or cortical R2*
was seen in stenotic kidneys even though a loss of volume
was perceived. The author therefore concluded that renal
atrophy secondary to a renal artery stenosis does not seem to
be associated with a decreased intrarenal oxygenation.
Similar findings were presented in a recent human study
on BOLD imaging in 14 kidneys with renal artery stenosis
and in 14 patients with essential hypertension.23 After a
standardized patient preparation that included renin–angio-
tensin blockade and controlled sodium intake MR measure-
ments at 3.0 T were performed. Even though the stenotic
kidneys revealed a smaller volume and a decreased tissue
perfusion compared with both the healthy contralateral side
and patients with essential hypertension, almost identical R2*
values—as in the present study—were found in all three sets
of kidneys (medullary R2* 38.9±0.7 vs. cortical R2* 17.8±
0.36Hz).23 These data also indicated that with stenosis-
induced reduced blood flow and volume, cortical and
medullary oxygenation was preserved, which is in line with
the data from this study. As pointed out by Evans et al.,24 a
potential pitfall in BOLD imaging is the assumption that
tissue oxygenation varies with blood oxygenation. As
demonstrated by that group in previous rabbit and rat
studies, renal cortical and medullary tissue pO2 can remain
almost unchanged also with altered renal blood flow.25 They
also reported on an increased renal venous blood oxygen
content with increasing renal blood flow, despite stable tissue
pO2.
26 Not only these studies but also the aforementioned
study of Gloviczki et al.23 support the concept of (diffusional)
arterio–venous oxygen shunting that might contribute to a
dynamic regulation of renal oxygenation. In view of these
findings, the results of this study appear less surprising but
supportive for the above discussed facts. The present results
underline that medullary and cortical R2* are not affected by
age, gender, or renal function but are in contrast kept
constant over a broad range of physiological states.
In contrast to interindividual studies, like this present
study, intraindividual BOLD-MRI studies with pharmacolo-
gical stimulation of the kidneys were able to differentiate
between aged kidneys and young kidneys.11 Various studies
have been published by the same group that could clearly
demonstrate that diabetic kidneys are characterized by an
altered response to water load than the normal kidneys.12
This approach seems more suitable for clinical application as
the published data on differentiation between different
kidney disease such as acute tubular necrosis or acute
rejection as in a publication by Han et al.27 In this study a
difference in the mean medullary R2* of diseased and healthy
kidneys was seen, but based on a single patient a differentia-
tion cannot be safely achieved.
Study limitations
This study suffers from two major limitations. First, the
patient group included was very heterogeneous which was
desired on the one hand to evaluate the influence of age,
gender, and renal function on cortical R2* and medullary
R2*. But this diversity within the patients also implied that
the ‘preparation’ of the patients might have differed
significantly. The previous intake of drugs such as ACE-
inhibitors or diuretics, which could have an impact on the
renal oxygenation, was not monitored and hence not
corrected for. This is on the other hand also a positive
aspect of this study as a widespread application of BOLD
imaging in renally impaired patients is fostered if no patient
preparation is required. Second, the GFR was only estimated
based on the MDRD formula, which is however not perfectly
suitable for patients with a GFR 460ml/min.
Conclusion
Medullary and cortical R2* values do not show significant
alterations in patients with various stages or renal function.
In addition, renal oxygenation as measured with BOLD-MRI
seems independent of age and gender. These data underline
that the broad application of renal BOLD-MRI seems not
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Figure 4 |Graphic depiction of MR2* and CR2* distribution as
a function of several parameters. Dot plots that demonstrate
no correlation between the age and medullary relaxation rate
(MR2*) or cortical relaxation rate (CR2*) at (a) 1.5 T or (b) 3.0 T.
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suitable as the level of intrarenal oxygenation seems to be
kept constant over time as well as a broad range of renal
function.
MATERIALS AND METHODS
Patients
Between August 2009 and May 2011, 400 patients who underwent
abdominal MR imaging at 1.5 T or 3.0 T were included into this
Institutional Review Board–approved study. Informed consent was
obtained from all patients. Indications for imaging were non-
specific and included, for e.g., staging and detection of abdominal
tumors and MR angiographies of the renal and mesenteric vessels.
Attribution of the patients to 1.5 Tor 3 Twas based on availability of
the MR systems. A detailed overview of the patient demographics is
presented in Table 2. If available current serum creatinine levels of
the patients were recorded. Serum creatinine levels were considered
as current, if they had been obtained not more than 14 days before
or after the MR imaging. The method of the creatinine assessment
was not registered. Based on the serum creatinine value the current
eGFR was calculated using the MDRD formula.28 The patients were
not prepared for MR imaging with regard to water and food intake
or with regard to medications. For those patients who were
examined with a contrast-enhanced MR angiography of the renal
arteries, the status of the renal arteries was noted as well: no relevant
stenosis (o49% diameter reduction) vs. relevant stenosis (X50%).
MR imaging
All measurements were performed on a 32-channel 1.5 T whole
body scanner (Siemens MAGNETOM Avanto 32 76, Siemens
Healthcare Sector, Erlangen, Germany) with a gradient strength of
45mT/m and slew rate of 200mT/m/ms or on a 32-channel 3-T
whole-body scanner (Siemens MAGNETOM Tim Trio 32 102)
with the same gradient performance and same coil design. For signal
reception, one body matrix with 6 independent receiver elements
and 6 elements of the inbuilt spine matrix were utilized, i.e., a total
of 12 independent receiver elements. To allow for correct positioning
of the BOLD acquisition, coronal and transversal half-Fourier
single-shot turbo spin-echo (HASTE) sequences (TR/TE—1200/
80ms, flip angle 1501, slice thickness 4mm (3.0 T), 5mm (1.5 T))
were acquired first. For the BOLD measurement a fast two-
dimensional gradient recalled echo (2D-GRE) sequence with 12
echoes was applied with the sequence parameters displayed in
Table 3. The 2D-GRE sequence was acquired during a single breath-
hold acquisition and always before the administration of the MR-
contrast agents.
Data analysis
BOLD images were analyzed on an OsiriX 3.7.1 64-bit Version
DICOM Mac-Pro Workstation (OsiriX Foundation, Geneva,
Switzerland) using the T2*-fitting tool of the software that yielded
parameter-coded T2* maps of the kidneys. On these images, regions
of interest were placed manually in the cortex and in the medulla by
one reader. This procedure was performed twice and the mean
results were used for further analysis. If cortex and medulla could
not be differentiated on the color-coded T2* parameter maps, the
definition of cortex and medulla was performed on the raw data
where with increasing echo time a better differentiation between
cortex and medulla can be seen. The regions of interest were then
copied from these raw data onto the T2* parameter map. The reader
was blinded to patient’s age, gender, and field strength. The order of
patients was randomized. The corresponding R2* values were
calculated as R2*¼ 1/T2* in 1/ms.
Data were transferred to an Excel 2010 (Microsoft, Redmond,
WA) spreadsheet. Further statistical analysis was performed with
MedCalc (Version 7.3, MedCalc Software, Mariakerke, Belgium). In
order to facilitate further analyses cortical and medullary R2* values
were averaged in those patients with two kidneys. If only one kidney
was present the measured cortical and medullary R2* were used.
Quantitative measures are displayed as means±standard deviations.
T-test analyses were performed to detect statistically significant
differences when the data revealed a normal distribution Wilcoxon-
rank sum tests were used in case of non-normal distribution.
A Kolmogorov–Smirnov test was used to test for normal distri-
bution. After Bonferroni correction for multiple testing, two-sided
P-values o0.005 were regarded as statistically significant. Pearson’s
correlation coefficient was calculated where appropriate. Data
analysis was performed separately for the data acquired at 1.5 T
and 3.0 T. Owing to the explorative character of the study no sample
size calculation was performed beforehand. The primary aim was to
assess the correlation between renal function, and cortical and
medullary R2*. Patients were also stratified in subgroups based on
the KDOQI criteria of chronic renal failure. As the MDRD formula
might yield erroneous results for patients with a GFR460ml/min,
the patients with KDQQI stage 1 and 2 disease were grouped
together. Secondary aims were the assessment of the impact of age
and gender on cortical and medullary R2*.
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Table 2 | Patient demographics of all patients with R2* values
N
Male/
female
Age range
(years)
Median
age (years)
Mean age±s.d.
(years) P-value
Total 342 211/131 21–92 60 59.0±15.9
1.5T 211 129/82 21–92 60 59.2±14.0 NS
3.0T 131 82/49 24–88 60 58.6±16.2 NS
Abbreviations: N, number of patients; NS, nonsignificant; R2*, relaxation rate; s.d.,
standard deviation.
Table 3 | Detailed sequence parameters of the 2D-GRE
sequence applied for renal BOLD imaging
2D-GRE 1.5 T 3.0 T
TR (ms) 106 106
TE (ms) 5–40 5–40
Number of echoes 12 12
Flip angle (1) 25 25
FOV (mmmm) 350 317 350 317
Matrix 256 231 256 231
Slice thickness (mm) 4 4
Spatial resolution (mm3) 1.4 1.4 4 1.4 1.4 4
Bandwidth (Hz/pixel) 390 390
Acquisition time (s) 24 24
Parallel imaging GRAPPA 2 GRAPPA 2
Orientation Transversal Transversal
Abbreviations: BOLD, blood oxygen level–dependent; 2D-GRE, two-dimensional
gradient recalled echo; FOV, field of view; TE, echo time; TR, repetition time.
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